Margaret Anderson

Margaret is a Managing Director with Deloitte Consulting LLS where she is focused on bringing forward her experience with trends in biomedical research innovation and patient engagement to help strengthen nonprofit organizations, as well as federal health and commercial life sciences programs. She joined Deloitte from FasterCures, a center of the Milken Institute where she was Executive Director. While at FasterCures, she oversaw programs advancing the science of patient input, examining the metrics for collaborative research models, and policy related to federal research. She has also worked on public health issues at the American Public Health Association and in a consulting and policy capacity for HIV/AIDS programs in the early years of the epidemic. She began her career at the Congressional Office of Technology Assessment looking at the impact of biotechnology and genetics on the economy and society.

Margaret currently serves on the Boards of Act for NIH, FasterCures, Friends of Cancer Research, and the Melanoma Research Alliance. Margaret has a Bachelor’s from the University of Maryland in Government and Politics and a Master’s from George Washington in Science, Technology, and Public Policy.